<DOC>
	<DOCNO>NCT02992197</DOCNO>
	<brief_summary>Rotavirus lead cause diarrhea child worldwide . Oral rotavirus vaccine work remarkably well high-income country , unclear reason underperform low-income country . A double-blind , randomize control trial perform evaluate whether use high dose currently license vaccine ( Rotarix , GlaxoSmithKline ) improve immune response among infant Dhaka , Bangladesh . Infants randomize 1:1 receive either standard double dose Rotarix 6 10 week life . Infants assess fecal vaccine shed serum rotavirus-specific IgA response determine vaccine immunogenicity .</brief_summary>
	<brief_title>The Effects Increased Inoculum Oral Rotavirus Vaccine Take Immunogenicity</brief_title>
	<detailed_description />
	<mesh_term>Rotavirus Infections</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>1 . Generally healthy infant ( determined medical officer ) 2 . Age 07 day enrolment 3 . Mother willing able provide sign informed consent 4 . Mother willing allow infant vaccinate accord study schedule 5 . Mother willing allow biological specimen , include blood , stool , saliva , collect infant accord study protocol 6 . Mother willing able adhere study schedule 1 . Obvious congenital malformation 2 . Birth weight ( know ) enrolment weight ( birth weight unknown ) &lt; 2000 gm 3 . Known immunocompromising condition infant 4 . Enrolment vaccine research trial 5 . Other household member enrol study</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>15 Weeks</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>Rotavirus</keyword>
	<keyword>Oral vaccine</keyword>
	<keyword>Vaccine underperformance</keyword>
	<keyword>Vaccine shed</keyword>
</DOC>